Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002001.SZ

STRONG BUYFLAG

Zhejiang NHU Company Ltd. · Healthcare · China · $13.3B · Avg Vol: $159M/d

99
StockRank
Q
75
V
61
M
68
P/E (TTM)
13.7x
ROE
20.4%
D/E
0.2x
Dividend %
3.3%
AI CONVICTION THESIS

Zhejiang NHU is a global leader in vitamins and nutrition chemicals. While it has strong manufacturing scale, it is energy-intensive and vulnerable to rising chemical feedstock costs, offsetting its CDMO-like market position.

COMPANY DESCRIPTION

Zhejiang NHU Company Ltd. is a global leader in the production of nutritional chemicals, specializing in vitamins (A, E, D3), methionine, and food additives. The company holds a dominant global market share in vitamins, leveraging its highly advanced chemical synthesis technologies and vertically integrated production processes to achieve industry-leading cost structures. Its competitive moat is sustained by high technical barriers, global regulatory approvals, and strong pricing power in the animal nutrition market.

FINANCIAL SUMMARY

Year2022202320242025CAGR
Revenue2.4B2.2B3.2B3.3B11.8%
EPS0.170.130.280.3323.6%
Shares3.1B3.1B3.1B3.1B-0.6%
Debt1.4B1.4B1.3B1.2B-6.1%
Equity3.5B3.7B4.3B4.8B11.6%
Op CF645M757M1.0B1.3B26.3%
Inv CF-567M-573M-558M-302M
Fin CF-188M-303M-334M-662M
Loading...
PRICE (1M)-13.1%
4.324.534.734.945.14Apr 30May 26Jun 15
SMA 50SMA 200
Close
$4.47
RSI (14)
46.6
52W High
$5.78
From 52W High
0.8%

SCORE BREAKDOWN

Quality
75
ROIC
21.1%92.1
ROE
20.4%89.1
GP/Assets
21.7%49.8
Op. Margin
35.1%95.1
FCF/Assets
12.4%91.0
Piotroski
83.5
Int. Cover
36.2x80.4
D/E Ratio
0.21x50.6
Current Ratio
2.82x50.3
Value
61
P/E (TTM)
13.7x77.5
EV/EBITDA
8.8x45.6
P/FCF
108.0x66.1
P/B
2.7x44.8
P/S
4.0x47.7
Div Yield
3.3%74.8
Momentum
68
52W High %
77%69.8
RS 6M
19%87.2
SMA 50/200
1.18x87.4
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+31%41.8
Q Growth
-3%38.0

FUNDAMENTALS

Market Cap
$13.3B
P/E (Forward)
10.5x
Gross Margin
42.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002001.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
002001.SZZhejiang NHU Company Ltd.(you)$13.3B99STRONG BUY
000538.SZYunnan Baiyao Group Co.,Ltd$13.2B91STRONG BUY
000423.SZDong-E-E-Jiao Co., Ltd.$4.8B99STRONG BUY
600566.SSHubei Jumpcan Pharmaceutical Co., Ltd.$3.8B99STRONG BUY
000963.SZHuadong Medicine Co., Ltd$7.5B84STRONG BUY
002603.SZShijiazhuang Yiling Pharmaceutical Co., Ltd.$4.0B96STRONG BUY
3692.HKHansoh Pharmaceutical Group Company Limited$24.3B83STRONG BUY
000999.SZChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd.$6.0B87STRONG BUY
000513.SZLivzon Pharmaceutical Group Inc.$4.0B94STRONG BUY
T14.SITianjin Pharmaceutical Da Ren Tang Group Corporation Limited$3.2B96STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.1%

Zhejiang NHU Company Ltd. (002001.SZ) — Stock Score Summary

Zhejiang NHU Company Ltd. (002001.SZ) has a MoatMap StockRank of 99/100 based on Quality (75/100), Value (61/100), and Momentum (68/100) factor scores. The current signal is STRONG BUY. Zhejiang NHU is a global leader in vitamins and nutrition chemicals. While it has strong manufacturing scale, it is energy-intensive and vulnerable to rising chemical feedstock costs, offsetting its CDMO-like market position.

Zhejiang NHU Company Ltd. is a global leader in the production of nutritional chemicals, specializing in vitamins (A, E, D3), methionine, and food additives. The company holds a dominant global market share in vitamins, leveraging its highly advanced chemical synthesis technologies and vertically integrated production processes to achieve industry-leading cost structures. Its competitive moat is sustained by high technical barriers, global regulatory approvals, and strong pricing power in the animal nutrition market.

Key Financial Metrics

Price$4.47
Market Cap$13.3B
P/E (TTM)13.74
P/E (Forward)10.51
Price/Book2.65
Return on Equity20.4%
Return on Invested Capital21.1%
Debt/Equity21.31
Gross Margin42.7%
Operating Margin35.1%
Revenue Growth15.7%
Dividend Yield3.3%
Free Cash Flow$123M

Zhejiang NHU Company Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang NHU Company Ltd.’s (002001.SZ) StockRank?
MoatMap’s StockRank for Zhejiang NHU Company Ltd. (002001.SZ) is 99/100, with a Strong Buy signal. It is a composite of Quality (75), Value (61), and Momentum (68) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang NHU Company Ltd. have an economic moat?
Zhejiang NHU Company Ltd. (002001.SZ) has a Quality factor score of 75/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang NHU Company Ltd. a buy, hold, or sell?
MoatMap’s current signal for Zhejiang NHU Company Ltd. (002001.SZ) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang NHU Company Ltd. in?
Zhejiang NHU Company Ltd. (002001.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).